Optimi Health Corp.
OPTHNasdaqCIK 2027329HealthcareFiscal year ends Sep 30
Financial statements for this company are not loaded yet.
Financial statements
This company’s XBRL filings carry none of the line items we standardize, so there are no figures to show.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| Yorkville Advisors Global, LP | 2026-06-30 | $1.0m | 199,000 | New+199,000 | |
| AdvisorShares Investments LLC | 2026-06-30 | $523.2k | 102,794 | New+102,794 | |
| TWO SIGMA SECURITIES, LLC | 2026-06-30 | $53.9k | 10,593 | New+10,593 | |
| UBS Group AG | 2026-06-30 | $29.9k | 5,872 | New+5,872 | |
| ROYAL BANK OF CANADA | 2026-06-30 | $10.0k | 1,964 | New+1,964 | |
| NATIONAL BANK OF CANADA /FI/ | 2026-06-30 | $3.1k | 598 | New+598 | |
| TD Waterhouse Canada Inc. | 2026-06-30 | $1.7k | 333 | New+333 | |
| Mariner, LLC | 2026-06-30 | $837 | 122,250 | New+122,250 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2026-06-30 | $692 | 136 | New+136 | |
| Arax Advisory Partners | 2026-06-30 | $254 | 50 | New+50 |
Recent filings
All 47 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2608:00 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-26 | 0001171843-26-006808 |
| 2026-10-2008:30 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-20 | 0001171843-26-006705 |
| 2026-10-0709:00 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-07 | 0001171843-26-006484 |
| 2026-09-2907:30 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-29 | 0001171843-26-006275 |
| 2026-09-2313:18 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-23 | 0001171843-26-006184 |
| 2026-09-2209:00 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-22 | 0001171843-26-006164 |
| 2026-09-1608:25 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-16 | 0001171843-26-006065 |
| 2026-09-1008:45 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-10 | 0001171843-26-005973 |
| 2026-09-0808:30 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-08 | 0001171843-26-005914 |
| 2026-08-2720:24 ET | 6-K | Report of a foreign private issuerPeriod 2026-08-26 | 0001171843-26-005754 |
Latest annual report
No annual report is in coverage for this company.
Forecast league
Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league
About the filer
- CIK
- 2027329
- Tickers
- OPTH
- Exchange
- Nasdaq
- SIC code
- 2834 Pharmaceutical Preparations
- Sector
- Healthcare
- Fiscal year ends
- Sep 30
- Incorporated in
- A1
- Filer category
- not reported
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 08:01 ET. Listed shows no prices and gives no investment advice.